In the U.K., two film readers evaluate mammograms for signs of cancer independent of one another. According to a recent study published by JAMA, changing the order in which the two readers examine a batch of mammograms did not result in reduced breast cancer detection rates. 

A new bill requiring private insurance companies to cover breast tomosynthesis, or 3D mammography, when prescribed by a cancer specialist has passed the Connecticut state legislature and now sits on Governor Dannel Malloy’s desk. The only question is: Will he sign it?

Researchers from the Barrow Neurological Institute at St. Joseph’s Hospital and Medical Center in Phoenix, Ariz., have created and tested a pen-sized imaging instrument to aid neurosurgeons in the visualization of individual tumor cells during ongoing brain operations, according to results of a study published in the April issue of Neurosurgical Focus.

ROCHESTER, N.Y., May 5 — Carestream now offers an oncology reading workflow for PET/CT studies that equips clinicians with new native tools for its enterprise image management system  that deliver both quantitative and qualitative information to help improve and expedite the reading process.

GE Healthcare announced this week that its Discovery NM/CT 670 CZT has been installed at Barnes-Jewish Hospital in St. Louis, marking the first time one of these systems has been installed in North America. 

More money than can be wisely allocated and properly coordinated has been pouring into lots of worthwhile projects in the wake of President Obama’s January establishment of the National Cancer Moonshot initiative to speed up cancer research. That’s a good problem to have, but it’s still a problem.

The use of whole-breast irradiation to treat stage I and II breast cancer appears to be increasing the incidence of radiation-associated angiosarcoma (RAS) of the breast, and radiologists play a crucial role in diagnosing the disease, four Harvard-affiliated radiologists write in a discussion piece published ahead of print in the American Journal of Roentgenology.

A readability analysis of 50 websites discussing treatment modalities for pancreatic cancer—one of the deadliest cancers and thus one of the most anxiety-producing after diagnosis—has found that, overall, the information is likely too hard to understand for vast swaths of the population.